This metabolic shift is especially relevant in rapidly proliferating cancer cells, which display increased UGCG expression and elevated GlcCer levels, often correlated with multidrug resistance and poor prognosis [122,135,143,144,145,146,147,148,149,150,151]. The gene discussed is UGCG; the disease is cancer.